Publication | Closed Access

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insights

Tobacco ControlThrombosisParadoxic Beneficial EffectsCardiovascular DiseaseHealth PolicyTobacco UseGusto-i TrialPharmacotherapyAcute Myocardial InfarctionPublic HealthMedicineCardiologyAnesthesiologyMyocardial Infarction